SHIM
INSM icon

Stone House Investment Management’s Insmed INSM Stock Holding History

Stone House Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.7K Sell
200
-2
-1% -$307 0.01% 226
2025
Q4 		$35.2K Buy
202
+2
+1% +$365 0.01% 199
2025
Q3 		$28.8K Buy
+200
New +$24.5K ﹤0.01% 196

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Stone House Investment Management's INSM Position: Q1 2026 in Review

Stone House Investment Management reduced its Insmed (INSM) stake by 0.99% in Q1 2026, selling an estimated $307 and leaving 200 shares worth $32.7K. The position accounts for 0.01% of the portfolio, ranked #226.

Stone House Investment Management first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $35.2K in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Stone House Investment Management held 200 shares of Insmed worth $32.7K as of Q1 2026.
  • Stone House Investment Management sold 2 Insmed shares in Q1 2026, an estimated $307.
  • Insmed made up 0.01% of Stone House Investment Management's portfolio in Q1 2026, its #226 holding.
  • Stone House Investment Management first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
  • Stone House Investment Management's Insmed position peaked at $35.2K in Q4 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.